| case report | Q2782326 |
| scholarly article | Q13442814 |
| P50 | author | Christian Morberg Wejse | Q45341538 |
| P2093 | author name string | Mikala Wang | |
| Jens Steen Olesen | |||
| P2860 | cites work | Occurrence and characterization of multiple novel genotypes of Mycobacterium immunogenum and Mycobacterium chelonae in metalworking fluids | Q23913787 |
| Infections caused by Scedosporium spp. | Q24657691 | ||
| Proposal of Mycobacterium peregrinum sp. nov., nom. rev., and elevation of Mycobacterium chelonae subsp. abscessus (Kubica et al.) to species status: Mycobacterium abscessus comb. nov | Q28243637 | ||
| A reduced linezolid dosage maintains favorable efficacy with minimal hematologic toxicity in a methicillin-resistant Staphylococcus aureus-infected patient with renal insufficiency | Q33403406 | ||
| Soft Tissue Infection Caused by Rapid Growing Mycobacterium following Medical Procedures: Two Case Reports and Literature Review | Q33682171 | ||
| Cutaneous aspergillosis. | Q33687314 | ||
| Increasing incidence of nontuberculous mycobacteria, Taiwan, 2000-2008 | Q34216173 | ||
| Host-pathogen interactions and immune evasion strategies in Francisella tularensis pathogenicity | Q34237666 | ||
| Nocardiosis: updates and clinical overview | Q34265302 | ||
| Diversity, community composition, and dynamics of nonpigmented and late-pigmenting rapidly growing mycobacteria in an urban tap water production and distribution system. | Q34802867 | ||
| Sporotrichosis: an overview and therapeutic options | Q34968193 | ||
| Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient? | Q35249608 | ||
| Mycobacteria in drinking water distribution systems: ecology and significance for human health. | Q36283999 | ||
| Erysipelothrix rhusiopathiae: an occupational pathogen | Q36635576 | ||
| An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases | Q36727850 | ||
| A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae | Q37144788 | ||
| The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment | Q38063474 | ||
| Update in tuberculosis and nontuberculous mycobacterial disease 2012. | Q38152788 | ||
| Non-tuberculous mycobacterial infections of the skin: a retrospective study of 29 cases | Q38480064 | ||
| Cutaneous Pseudallescheria boydii/Scedosporium apiospermum Complex (Molecular type: Scedosporium apiospermum [Clade 4]) Infection: A Case Report and Literature Review of Cases from Japan. | Q38652553 | ||
| Detection and identification of mycobacteria in the Lisbon water distribution system. | Q39737692 | ||
| Mycobacterium chelonae infections associated with bee venom acupuncture | Q42240028 | ||
| Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997 2003. | Q42764847 | ||
| Assessment of in vitro susceptibility to antimicrobials of rapidly growing mycobacteria by E-test | Q43267382 | ||
| Successful treatment of disseminated Mycobacterium chelonae infection with linezolid | Q43732842 | ||
| Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae | Q44065541 | ||
| The use of rpoB sequence analysis in the differentiation of Mycobacterium abscessus and Mycobacterium chelonae: a critical judgement in cystic fibrosis? | Q44557837 | ||
| Molecular typing of Mycobacterium chelonae isolates from a pseudo-outbreak involving an automated bronchoscope washer | Q47285181 | ||
| Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin. | Q54264330 | ||
| Contamination of Endoscopes and Endoscope Washers by Atypical Mycobacteria | Q68196200 | ||
| Infection in rheumatoid arthritis | Q71754727 | ||
| The relationship between the in vitro drug susceptibility of opportunist mycobacteria and their in vivo response to treatment | Q74030479 | ||
| Primary cutaneous cryptococcosis: a distinct clinical entity | Q78827869 | ||
| Dissemination of a localized cutaneous infection with Mycobacterium chelonae under immunosuppressive treatment | Q80635577 | ||
| [Disseminated cutaneous infection by Mycobacterium chelonae after botulinic toxin injection in an immunosuppressed patient] | Q81333522 | ||
| Soft tissue infection caused by Mycobacterium chelonae following a liposculpture and lipofilling procedure | Q83145632 | ||
| P921 | main subject | rheumatoid arthritis | Q187255 |
| linezolid | Q411377 | ||
| Mycobacterium chelonae | Q6947002 | ||
| hand infection | Q105342716 | ||
| P577 | publication date | 2017-01-30 | |
| P1433 | published in | BMJ case reports | Q27723081 |
| P1476 | title | Mycobacterium chelonae hand infection after steroid injection in a patient with rheumatoid arthritis receiving long-term linezolid therapy | |
| P478 | volume | 2017 |
Search more.